TABLE 3.

Hospitalization Outcomes of PLWH With Laboratory-Confirmed COVID-19 Admitted to MHS, October 3, 2020–November 5, 2020, by HIV Viral Suppression Status

Outcomes by HIV Viral Suppression Status, Unadjusted				Adjusted Association of Unsuppressed Viral Load with Outcome (Reference: Suppressed Viral Load, <40 Copies/mL)
Outcome	Unsuppressed Events/Total Eligible (%)	Suppressed (<40 Copies/mL) Events/Total Eligible (%)	P (Unadjusted)	Outcome	Adjusted Hazard Ratio (95% CI)	P (Adjusted)
Intubation	0/15 (0%)	21/81 (26%)	0.04	Time to intubation	N/A	N/A
Acute kidney injury*	7/13 (54%)	38/67 (57%)	0.85	Time to acute kidney injury	0.89 (0.45 to 1.74)	0.74
Length of stay†, d (median, IQR)	7 (4–12)	5 (3–8)	0.40	Time to discharge	1.58 (0.97 to 2.55)	0.06
Death in hospital	0/15 (0%)	22/81 (27%)	0.02	Time to death	N/A	N/A

Associations of unsuppressed viral load with each outcome are adjusted for age, sex, race/ethnicity, history of chronic lower respiratory disease, BMI, calendar time, and account for competing risks of other outcomes as appropriate. Four HIV-positive patients did not have HIV RNA measurements available. Adjusted associations of unsuppressed viral load with time to intubation and time to death could not be estimated due to no events among unsuppressed.

^*Excludes patients with end-stage renal disease (N = 17).

^†Includes patients discharged alive during study period (N = 78).